Clinical Trials Directory

Trials / Unknown

UnknownNCT06058052

Prevalence of OSA in Patients of ILD

Pattern Of Association Between Obstructive Seep Apnea and Interstitial Lung Disease

Status
Unknown
Phase
Study type
Observational
Enrollment
81 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

To evaluate the clinical predictors of OSA in patients with ILD

Detailed description

Interstitial lung diseases (ILDs) are a group of heterogeneous disorders characterized by varying degrees of fibrosis and inflammation of lung parenchyma. Obstructive sleep apnea is a type of sleep disordered breathing characterized by repeated episodes of apnea and hypopnea during sleep due to narrowing or occlusion of the upper airway. It was found that the prevalence of OSA is as high as 80% among patients with idiopathic pulmonary fibrosis (IPF). Despite this common association, there is limited research in this field. There is great need for further studies to highlight this association and understand the underlying pathophysiological mechanisms implicated in those patients, to ultimately guide the appropriate management.

Conditions

Timeline

Start date
2023-10-20
Primary completion
2024-09-28
Completion
2024-12-25
First posted
2023-09-28
Last updated
2023-09-28

Source: ClinicalTrials.gov record NCT06058052. Inclusion in this directory is not an endorsement.